Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study

~58 mi. (Columbia, Missouri, +523 more cities)

University of Missouri - Ellis Fischel

Clear Cell Renal Cell Carcinoma

cabozantinib, +2 more drugs

immunotherapy, +1 more type

T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial

~58 mi. (Columbia, Missouri, +576 more cities)

University of Missouri - Ellis Fischel

ERBB2 Amplification, +1 more biomarker

Breast Carcinoma

ado-trastuzumab emtansine, +1 more drug

targeted therapy

Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy

~58 mi. (Columbia, Missouri, +744 more cities)

University of Missouri - Ellis Fischel

Breast Carcinoma

axillary lymph node dissection, +1 more drug

radiation therapy, +1 more type

Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer

~58 mi. (Columbia, Missouri, +269 more cities)

University of Missouri - Ellis Fischel

ER Positive, +1 more biomarker

Invasive Breast Carcinoma

radiation therapy, +1 more drug

radiation therapy

A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia

~58 mi. (Columbia, Missouri, +173 more cities)

Columbia Regional

B-Cell Lymphoblastic Leukemia/Lymphoma

asparaginase Erwinia chrysanthemi, +12 more drugs

chemotherapy, +2 more types

A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation Therapy

~58 mi. (Columbia, Missouri, +233 more cities)

University of Missouri - Ellis Fischel

Prostate Adenocarcinoma

degarelix, +4 more drugs

hormone therapy, +1 more type

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

~58 mi. (Columbia, Missouri, +825 more cities)

University of Missouri - Ellis Fischel

AKT1 Mutation, +91 more biomarkers

Breast Carcinoma, +3 more conditions

adavosertib, +26 more drugs

immunotherapy, +1 more type

Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair

~58 mi. (Columbia, Missouri, +656 more cities)

University of Missouri - Ellis Fischel

Deficient DNA Mismatch Repair (dMMR), +8 more biomarkers

Colon Adenocarcinoma, +1 more condition

atezolizumab, +3 more drugs

chemotherapy, +1 more type

CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy

~58 mi. (Columbia, Missouri, +533 more cities)

University of Missouri - Ellis Fischel

ERBB2 Amplification, +1 more biomarker

Invasive Breast Carcinoma

ado-trastuzumab emtansine, +6 more drugs

chemotherapy, +2 more types

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

~58 mi. (Columbia, Missouri, +235 more cities)

University of Missouri - Ellis Fischel

Prostate Adenocarcinoma

abiraterone, +9 more drugs

hormone therapy, +2 more types

Assessment of Efficacy and Safety of Monalizumab Plus Cetuximab Compared to Placebo Plus Cetuximab in Recurrent or Metastatic Head and Neck Cancer

~58 mi. (Columbia, Missouri, +178 more cities)

Research Site

Head and Neck Squamous Cell Carcinoma

cetuximab, +1 more drug

immunotherapy, +1 more type

Comparing the New Anti-cancer Drug Eribulin With or Without Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial Cancer

~58 mi. (Columbia, Missouri, +215 more cities)

University of Missouri - Ellis Fischel

Urothelial Carcinoma

eribulin, +1 more drug

chemotherapy